Quick Answer
HOOKIPA Pharma Inc. reported Total Assets of $82.55 million for the year ending 2024.
- HOOKIPA Pharma Inc. showed a decrease of -48.8% in Total Assets from 2023 to 2024.
- This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $101.98 million | Q2 2019: $168.10 million | Q3 2019: $152.04 million | Q1 2020: $135.97 million | Q2 2020: $133.27 million | Q3 2020: $121.27 million | Q1 2021: $169.94 million | Q2 2021: $166.16 million | Q3 2021: $142.17 million | Q1 2022: $195.71 million | Q2 2022: $172.21 million | Q3 2022: $151.53 million | Q1 2023: $163.09 million | Q2 2023: $191.11 million | Q3 2023: $164.01 million | Q1 2024: $145.87 million | Q2 2024: $125.05 million | Q3 2024: $109.73 million | Q4 2024: $82.55 million | Q1 2025: $61.26 million.
- Over the full 7 years of available data (2018 to 2024), HOOKIPA Pharma Inc.'s Total Assets has grown by 20.9%.
- Historical annual values: Fiscal year 2024: $82.55 million | Fiscal year 2023: $161.34 million | Fiscal year 2022: $170.45 million | Fiscal year 2021: $126.05 million | Fiscal year 2020: $187.82 million | Fiscal year 2019: $143.75 million | Fiscal year 2018: $68.25 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: